Rosa Camerlingo

1.8k total citations
41 papers, 1.3k citations indexed

About

Rosa Camerlingo is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rosa Camerlingo has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rosa Camerlingo's work include Cancer Cells and Metastasis (12 papers), MicroRNA in disease regulation (4 papers) and Melanoma and MAPK Pathways (4 papers). Rosa Camerlingo is often cited by papers focused on Cancer Cells and Metastasis (12 papers), MicroRNA in disease regulation (4 papers) and Melanoma and MAPK Pathways (4 papers). Rosa Camerlingo collaborates with scholars based in Italy, United States and Malaysia. Rosa Camerlingo's co-authors include Giuseppe Pirozzi, Virginia Tirino, Gaetano Rocco, Renato Franco, Nicola Normanno, Francesca Paino, Maria Vincenza Carriero, Donatella Malanga, Giuseppe Viglietto and Nicola Martucci and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Rosa Camerlingo

40 papers receiving 1.3k citations

Peers

Rosa Camerlingo

ONCOL

IMMUN

PRM

Xianda Zhao United States

Shailendra K. Gautam United States

Pedro P. López‐Casas Spain

Ernst J.A. Steller Netherlands

V. М. Perelmuter Russia

Jonathan F. Anker United States

Deepak Kanojia United States

Xinhui Wang United States

Manuela Porru Italy

Jichao Qin China

Xianda Zhao United States

Rosa Camerlingo

545 ×0.8

ONCOL

631 ×1.0

363 ×1.1

306 ×1.2

IMMUN

130 ×0.6

PRM

Citations per year, relative to Rosa Camerlingo Rosa Camerlingo (= 1×) peers Xianda Zhao

Countries citing papers authored by Rosa Camerlingo

Since Specialization

Citations

This map shows the geographic impact of Rosa Camerlingo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Camerlingo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Camerlingo more than expected).

Fields of papers citing papers by Rosa Camerlingo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Camerlingo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Camerlingo. The network helps show where Rosa Camerlingo may publish in the future.

Co-authorship network of co-authors of Rosa Camerlingo

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Camerlingo. A scholar is included among the top collaborators of Rosa Camerlingo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Camerlingo. Rosa Camerlingo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosa, Viviana De, Caterina De Rosa, Daniela Omodei, et al.. (2025). Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System. International Journal of Molecular Sciences. 26(14). 6825–6825.

Napolitano, Giuliana, Carmelina Antonella Iannuzzi, Iris Maria Forte, et al.. (2024). Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell Death. International Journal of Molecular Sciences. 25(24). 13475–13475. 2 indexed citations

Costa, Aurora, Iris Maria Forte, Francesca Pentimalli, et al.. (2024). Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells. Frontiers in Oncology. 14. 1418951–1418951. 3 indexed citations

Barone, Daniela, Carmelina Antonella Iannuzzi, Iris Maria Forte, et al.. (2023). The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment. Frontiers in Oncology. 13. 1117262–1117262. 1 indexed citations

Moriello, Aniello Schiano, Fiorentina Roviezzo, Fabio Arturo Iannotti, et al.. (2022). First Evidence of the Protective Effects of 2-Pentadecyl-2-Oxazoline (PEA-OXA) in In Vitro Models of Acute Lung Injury. Biomolecules. 13(1). 33–33. 5 indexed citations

Cerqua, Ida, Soraia K.P. Costa, António G. Soares, et al.. (2022). Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapy. Pharmacological Research. 186. 106536–106536. 3 indexed citations

Roca, Maria Serena, Tania Moccia, Federica Iannelli, et al.. (2022). HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation. Journal of Experimental & Clinical Cancer Research. 41(1). 83–83. 36 indexed citations

Forte, Iris Maria, Paola Indovina, Serena Montagnaro, et al.. (2021). The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach. Viruses. 13(12). 2458–2458. 15 indexed citations

Palinski, Wulf, Maria Monti, Rosa Camerlingo, et al.. (2021). Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients. Cell Death and Disease. 12(9). 797–797. 22 indexed citations

10.

Camerlingo, Rosa, Laura Marra, Giuseppina Rea, et al.. (2019). Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation. PLoS ONE. 14(7). e0219597–e0219597. 30 indexed citations

11.

Camerlingo, Rosa, Maria Vincenza Carriero, Giuseppe Pirozzi, et al.. (2018). Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells. International Journal of Oncology. 53(3). 1149–1159. 20 indexed citations

12.

Trotta, Anna Maria, Sara Santagata, Serena Zanotta, et al.. (2018). Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity. Journal of Experimental & Clinical Cancer Research. 37(1). 297–297. 18 indexed citations

13.

Camerlingo, Rosa, Nicola Mozzillo, Giuseppe Pirozzi, et al.. (2017). Phenotype characterization of human melanoma cells resistant to dabrafenib. Oncology Reports. 38(5). 2741–2751. 26 indexed citations

14.

Mozzillo, Nicola, Ester Simeone, Marcello Curvietto, et al.. (2015). Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy. OncoImmunology. 4(6). e1008842–e1008842. 55 indexed citations

15.

Camerlingo, Rosa, Giuseppe Andrea Ferraro, Francesco De Francesco, et al.. (2013). The role of CD44+/CD24−/low biomarker for screening, diagnosis and monitoring of breast cancer. Oncology Reports. 31(3). 1127–1132. 40 indexed citations

16.

Pirozzi, Giuseppe, Virginia Tirino, Rosa Camerlingo, et al.. (2013). Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. Oncology Reports. 29(5). 1763–1768. 52 indexed citations

17.

Tirino, Virginia, Rosa Camerlingo, Katia Bifulco, et al.. (2013). TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. Cell Death and Disease. 4(5). e620–e620. 106 indexed citations

18.

Franco, Renato, Giuseppe Pirozzi, Stefania Scala, et al.. (2011). CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood. European Journal of Cardio-Thoracic Surgery. 41(2). 368–375. 32 indexed citations

19.

Tirino, Virginia, Rosa Camerlingo, Renato Franco, et al.. (2009). The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer☆☆☆. European Journal of Cardio-Thoracic Surgery. 36(3). 446–453. 168 indexed citations

20.

Aguglia, Umberto, Antonio Gambardella, R. L. Oliveri, et al.. (1990). Triphasic Waves and Cerebral Tumors. European Neurology. 30(1). 1–5. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact